Zeteo Biomedical Introduces OrionMRQ™ Nasal Vaccine Delivery Device – The Durango Herald

ByLance T. Lee

May 4, 2022

Zeteo’s patient-centric needle-free nasal delivery systems are commercially scalable to facilitate rapid deployment of drugs and vaccines to global populations

PFLUGERVILLE, Texas, May 4, 2022 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical LLC today announced the availability of the ZEOx1 OrionMRQ™ Nasal Drug and Vaccine Delivery Device. Zeteo’s latest innovative delivery device provides pharmaceutical and biotechnology companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered systemic delivery of a unit dose via the nasal route.

Nasal administration allows rapid, needle-free systemic absorption into the body through the nose. Nasal administration of vaccines can invoke a rapid local immune response in the airways, which is often the primary route of infection for contagious pathogens such as pandemic influenza or coronavirus. The ZEOx1 OrionMRQ™ device is intuitive to use, allowing for either patient self-administration or caregiver administration with configurations available for adults and children.

The OrionMRQ ​​Refillable Nasal Delivery Device has the capacity to store up to four unit doses in the built-in storage compartment. The device is compact, making it easy to carry in a pocket or purse. Zeteo’s intranasal delivery devices incorporate new packaging technology using a flexible Form Fill Seal (FFS) foil, packaging the drug or vaccine in a unit dose blister reducing costs and eliminating supply chain constraints. supply of glass bottles.

ZEOx1™ blister packaging provides exceptional barrier properties to protect the drug or vaccine during storage and transportation and can be stored at room temperature, refrigerated or frozen storage conditions. ZEOx1™ packaging technology is commercially scalable to produce millions of doses per day; a critically important requirement for the rapid and cost-effective deployment of vaccines and medical countermeasures to global populations.

About Zeteo Biomedical LLC:

Zeteo Biomedical™ is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology, combination drug/device product development services and fill/finish packaging technology for pharmaceutical, biopharmaceutical, biological and botanical products for intranasal, nasal, -brain, ophthalmic, sublingual and animal care.

For more information, visit the Zeteo website: https://www.zeteobiomed.com/

MULTIMEDIA:

*PHOTO link for media: https://www.Send2Press.com/300dpi/22-0504-s2p-zeox1-orionmrq-300dpi.jpg

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

NEWS SOURCE: Zeteo Biomedical LLC

This press release has been issued on behalf of the source of the information (Zeteo Biomedical LLC) which is solely responsible for its accuracy, by Send2Press® Newswire. The information is believed to be accurate but not guaranteed. Story ID: 81399 APDF-R8.5

&Copy; 2022 Send2Press®, a press release and electronic marketing service of NEOTROPE®, California, USA.

To see the original version, visit: https://www.send2press.com/wire/zeteo-biomedical-introduces-orionmrq-nasal-delivery-device-for-vaccines/

Disclaimer: The content of this press release was not created by The Associated Press (AP).


Source link